Literature DB >> 10881996

Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997.

J L Sankalé1, D Hamel, A Woolsey, T Traoré, T C Dia, A Guèye-Ndiaye, M Essex, T Mboup, P Kanki.   

Abstract

OBJECTIVE: Few studies have been able to track the genetic diversity of HIV-1 viruses in human populations over time. We analyzed the molecular evolution of subtype A over a 10-year period, in a cohort of female sex workers with a known time of infection. STUDY DESIGN/
METHODS: We amplified and sequenced the C2-V3 region of the surface envelope glycoprotein from 73 HIV-1-infected women, infected between 1987-1997.
RESULTS: Fifty-one patients were infected by subtype A viruses. The viruses demonstrated significant diversification (p < 0.001) with mean genetic distance increasing from 8.6% in 1989 to 15.9% in 1997. The slope of the fitted curve suggested a rate of diversification of 0.7% per year. The majority of subtype A viruses clustered with HIV-1 subtype A/G recombinant form (IbNG).
CONCLUSION: The genetic diversity of HIV-1 subtype A infections doubled over the first 10 years of this high risk population's epidemic, suggesting that implementation of vaccines early in the epidemic may have a higher likelihood of success based on levels of genetic diversity. The A/G recombinant form (IbNG) has taken epidemic proportions in West Africa. This is of particular importance in understanding the epidemiology of HIV-1 subtypes in Africa and to further dissect the potential phenotypic and biological characteristics of these viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881996

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  9 in total

1.  Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.

Authors:  B Chaplin; G Eisen; J Idoko; D Onwujekwe; E Idigbe; I Adewole; W Gashau; S Meloni; A D Sarr; J L Sankalé; E Ekong; R L Murphy; P Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

2.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

3.  Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.

Authors:  Seema Thakore Meloni; Jean-Louis Sankalé; Donald J Hamel; Geoffrey Eisen; Aissatou Guéye-Ndiaye; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.

Authors:  Seema Thakore Meloni; Bohye Kim; Jean-Louis Sankalé; Donald J Hamel; Sodsai Tovanabutra; Souleymane Mboup; Francine E McCutchan; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Authors:  V Novitsky; N Rybak; M F McLane; P Gilbert; P Chigwedere; I Klein; S Gaolekwe; S Y Chang; T Peter; I Thior; T Ndung'u; F Vannberg; B T Foley; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Authors:  N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.

Authors:  Shaun K Rodriguez; Abdoulaye Dieng Sarr; Adam MacNeil; Seema Thakore-Meloni; Aissatou Gueye-Ndiaye; Ibrahima Traoré; Mamadou C Dia; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection.

Authors:  Indu Mani; Peter Gilbert; Jean-Louis Sankalé; Geoffrey Eisen; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 9.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.